Arcus Biosciences (NYSE:RCUS) Releases Earnings Results, Beats Expectations By $0.17 EPS

Arcus Biosciences (NYSE:RCUS) Releases Earnings Results, Beats Expectations By $0.17 EPS

Arcus Biosciences (NYSE:RCUS - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.72) EPS for the quarter, topping analysts' consensus estimates of ($0.89) by $0.17. Arcus Biosciences had a negative return on equity of 68.97% and a negative net margin of 156.36%.The business had revenue of $41.00 million for the quarter, compared to analysts' expectations of $21.98 million. The firm's revenue for the…